James Hurley is an experienced professional in the field of precision medicine and assay development, currently serving as Associate Director and Precision Medicine Lead at AstraZeneca since November 2022. Prior roles include Senior Scientist and Manager at BioTrove, where James led the development of TaqMan qPCR technology for the OpenArray platform, and Senior Scientist at Exosome Diagnostics, with a focus on creating assays for metastatic castration-resistant prostate cancer. James has also held various scientific positions at organizations such as Genome Therapeutics, Life Technologies, and NSG Consulting LLC, where responsibilities included developing novel genotyping methods and leading research and development initiatives. James earned a Ph.D. in Biochemistry from the University of London and a BSc in Biochemistry from the University of Bristol.
This person is not in the org chart
This person is not in any teams
This person is not in any offices